The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Open accessThe DOI matches its Crossref record; 186 of the 187 references it cites were found in a registry or an index.
Abstract
Following the discovery of T helper 17 (TH17) cells, the past decade has witnessed a major revision of the TH subset paradigm and substantial progress has been made in deciphering the molecular mechanisms of T cell lineage commitment and function. In this Review, we focus on the recent advances that have been made regarding the transcriptional control of TH17 cell plasticity and stability, as well as the effector functions of TH17 cells, and we highlight the mechanisms of IL-17 signalling in mesenchymal and barrier epithelial tissues. We also discuss the emerging clinical data showing that IL-17-specific and IL-23-specific antibody treatments are remarkably effective for treating many immune-mediated inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17 induces IL-6 and G-CSF, cytokines that promote myeloid-driven innate inflammation”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Gaffen et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways
Kim, J. S., Sklarz, T., Banks, L. B., Gohil, M., Waickman, A. T., Skuli, N., Krock, B. L., Luo, C. T., Hu, W., Pollizzi, K. N., et al. (2013) · Nature Immunology · doi:10.1038/ni.2607 · Cited by 85
RetractedMosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Self-citationHarrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Self-citationVeldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Research works printed but not linked: 1
- Ghoreschi K Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling Nature 467 967 971 20962846 PMC3108066 · DOI · Paper page
Cited by
Items 101–200 of 1,000
Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics
Lu, Q., Yang, M.-F., Liang, Y.-J., Xu, J., Xu, H.-M., Nie, Y.-Q., Wang, L.-S., Yao, J., & Li, D.-F. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s353038 · Cited by 200
“A recent study has demonstrated that Th1-type cytokine TNF-α can synergize with IFN-γ to kill IECs and disrupt gut epithelial barrier function through the CASP8-JAK1/2-STAT1 module.83 Th17 cells are first discovered in 2005 and play a crucial role in protecting the host against extracellular bacterial and fungal infec…”
BackgroundIL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications
von Stebut, E., Boehncke, W.-H., Ghoreschi, K., Gori, T., Kaya, Z., Thaci, D., & Schäffler, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03096 · Cited by 199
Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer
Sammarco, G., Varricchi, G., Ferraro, V., Ammendola, M., De Fazio, M., Altomare, D. F., Luposella, M., Maltese, L., Currò, G., Marone, G., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092106 · Cited by 198
“IL-17 is a pleiotropic cytokine [211] identified in several tumours including gastric cancer [212,213].”
BackgroundLuo, X., Chen, O., Wang, Z., Bang, S., Ji, J., Lee, S. H., Huh, Y., Furutani, K., He, Q., Tao, X., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.06.015 · Cited by 198
Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci
Tsoi, L. C., Spain, S. L., Ellinghaus, E., Stuart, P. E., Capon, F., Knight, J., Tejasvi, T., Kang, H. M., Allen, M. H., Lambert, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8001 · Cited by 195
IL-27-induced modulation of autoimmunity and its therapeutic potential
Meka, R. R., Venkatesha, S. H., Dudics, S., Acharya, B., & Moudgil, K. D. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.08.001 · Cited by 195
“Th17 cells produce pro-inflammatory cytokines IL-17, IL-22, and granulocyte macrophage colony-stimulating factor (GM-CSF), which play a role in the pathogenesis of several autoimmune disorders [35, 36].”
BackgroundCancers Related to Immunodeficiencies: Update and Perspectives
Mortaz, E., Tabarsi, P., Mansouri, D., Khosravi, A., Garssen, J., Velayati, A., & Adcock, I. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00365 · Cited by 190
Beurel, E., & Lowell, J. A. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.08.001 · Cited by 187
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies
Davis, J. S., Ferreira, D., Paige, E., Gedye, C., & Boyle, M. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00035-19 · Cited by 187
“IL-12 is also produced by neutrophils (788).”
van Hamburg, J. P., & Tas, S. W. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.12.006 · Cited by 186
Advances in Understanding the Immunological Pathways in Psoriasis
Georgescu, S. R., Tampa, M. Ş., Căruntu, C., Sârbu, M. I., Mitran, C. I., Mitran, M.-I., Matei, C., Constantin, C., & Neagu, M. T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030739 · Cited by 186
IL‐17: overview and role in oral immunity and microbiome
Abusleme, L., & Moutsopoulos, N. (2017) · Oral Diseases · doi:10.1111/odi.12598 · Cited by 183
Fatkhullina, A. R., Peshkova, I. O., Dzutsev, A., Aghayev, T., McCulloch, J. A., Thovarai, V., Badger, J. H., Vats, R., Sundd, P., Tang, H.-Y., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.09.011 · Cited by 181
“Anti-cytokine therapies show promising results in many autoimmune diseases, including inflammatory bowel disease (IBD), psoriasis and arthritis (Gaffen et al., 2014) and, recently, atherosclerosis (Ridker et al.”
InfluentialNeutrophils in the Tumor Microenvironment
Wu, L., Saxena, S., & Singh, R. K. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-35723-8_1 · Cited by 180
Shin, B., Benavides, G. A., Geng, J., Koralov, S. B., Hu, H., Darley-Usmar, V. M., & Harrington, L. E. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.022 · Cited by 180
“However, abnormal function of Th17 cells mediates chronic inflammatory disorders, including multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (Gaffen et al., 2014; Ghoreschi et al., 2011).”
BackgroundInfluentialSingh, T. P., Zhang, H. H., Borek, I., Wolf, P., Hedrick, M. N., Singh, S. P., Kelsall, B. L., Clausen, B. E., & Farber, J. M. (2016) · Nature Communications · doi:10.1038/ncomms13581 · Cited by 180
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study
Feagan, B. G., Panés, J., Ferrante, M., Kaser, A., D'Haens, G. R., Sandborn, W. J., Louis, E., Neurath, M. F., Franchimont, D., Dewit, O., et al. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30233-4 · Cited by 157
Conti, H. R., Bruno, V. M., Childs, E. E., Daugherty, S., Hunter, J. P., Mengesha, B. G., Saevig, D. L., Hendricks, M. R., Coleman, B. M., Brane, L., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.10.001 · Cited by 177
“OECs do not express IL-17 (Huppler et al., 2015) but do express the IL-17R (Gaffen et al., 2014).”
BackgroundSelf-citationTranscriptional Regulators of T Helper 17 Cell Differentiation in Health and Autoimmune Diseases
Capone, A., & Volpe, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00348 · Cited by 177
“The binding of IL-17A with its receptor activates the target cells, such as epithelial cells, endothelial cells, and fibroblasts (3, 4, 8) and induces CXCL1, CXCL2, and CXCL8, which attract myeloid cells such as neutrophils to the infected or injured tissue (9); IL-6 and G-CSF, which promotemyeloid-driven innate infla…”
BackgroundCytokines in Graft-versus-Host Disease
Henden, A. S., & Hill, G. R. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500117 · Cited by 176
Lévy, R., Okada, S., Béziat, V., Moriya, K., Liu, C., Chai, L. Y. A., Migaud, M., Hauck, F., Al Ali, A., Cyrus, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618300114 · Cited by 174
IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy
Krueger, J. G., Eyerich, K., Kuchroo, V. K., Ritchlin, C. T., Abreu, M. T., Elloso, M. M., Fourie, A. M., Fakharzadeh, S. S., Sherlock, J. P., Yang, Y., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1331217 · Cited by 175
Self-citationTargeted Immunotherapy for Autoimmune Disease
Jung, S. M., & Kim, W.-U. (2022) · Immune Network · doi:10.4110/in.2022.22.e9 · Cited by 171
“Most importantly, IL-23 stabilizes the pathogenic features of Th17 cells through maintenance of Th17 signature genes, suppression of repressive factors, upregulation of IL-23R expression, and induction of effector genes (77,78).”
BackgroundSalivary cytokines as biomarkers of periodontal diseases
Jaedicke, K. M., Preshaw, P. M., & Taylor, J. J. (2016) · Periodontology 2000 · doi:10.1111/prd.12117 · Cited by 171
“Interleukin-17 is produced by Th17 cells after activation of the adaptive immunity and serves to reinforce pro-inflammatory immune responses [35].”
BackgroundPsoriasis: Classical vs. Paradoxical. The Yin-Yang of TNF and Type I Interferon
Mylonas, A., & Conrad, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02746 · Cited by 172
Tang, C., Kakuta, S., Shimizu, K., Kadoki, M., Kamiya, T., Shimazu, T., Kubo, S., Saijo, S., Ishigame, H., Nakae, S., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0134-y · Cited by 172
T2-“Low” Asthma: Overview and Management Strategies
Fitzpatrick, A. M., Chipps, B. E., Holguín, F., & Woodruff, P. G. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.11.006 · Cited by 170
Translating Immunology into Therapeutic Concepts for Inflammatory Bowel Disease
Uhlig, H. H., & Powrie, F. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053055 · Cited by 169
DDX5 and its associated lncRNA Rmrp modulate TH17 cell effector functions
Huang, W., Thomas, B., Flynn, R. A., Gavzy, S. J., Wu, L., Kim, S. V., Hall, J. A., Miraldi, E. R., Ng, C. P., Rigo, F., et al. (2015) · Nature · doi:10.1038/nature16193 · Cited by 167
RetractedCuthbert, R. J., Watad, A., Fragkakis, E. M., Dunsmuir, R., Loughenbury, P., Khan, A., Millner, P. A., Davison, A., Marzo-Ortega, H., Newton, D., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215210 · Cited by 166
Pavlidis, P., Tsakmaki, A., Pantazi, E. D., Li, K., Cozzetto, D., Digby-Bell, J. L., Yang, F., Lo, J. W., Alberts, E., Costa, A. C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33331-8 · Cited by 170
Chen, K., & Kolls, J. K. (2017) · Gene · doi:10.1016/j.gene.2017.01.016 · Cited by 164
“Accumulating data also suggest that IL-23 is essential for the maturation and maintenance of the Th17 lineage (Gaffen et al., 2014).”
BackgroundSkin Immunity to Candida albicans
Kashem, S. W., & Kaplan, D. H. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.04.007 · Cited by 147
“Similarly, IL-17RE was dispensable for protection against candidiasis, further demonstrating the specific necessity for IL-17A/F signaling [80].”
BackgroundInfluentialInterleukin-17A: The Key Cytokine in Neurodegenerative Diseases
Chen, J., Liu, X., & Zhong, Y. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.566922 · Cited by 165
“IL-17A also induces the expression of IL-6 and granulocyte colony-stimulating factor (G-CSF), which promotes myeloid-driven innate inflammation (Gaffen et al., 2014).”
BackgroundSu, Y., Huang, J., Zhao, X., Lu, H., Wang, W., Yang, X. O., Shi, Y., Wang, X., Lai, Y., & Dong, C. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau9657 · Cited by 146
Systemic effects of IL-17 in inflammatory arthritis
Beringer, A., & Miossec, P. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0243-5 · Cited by 162
Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD
Tindemans, I., Joosse, M. E., & Samsom, J. N. (2020) · Cells · doi:10.3390/cells9010110 · Cited by 163
Mahil, S. K., Dand, N., Mason, K. J., Yiu, Z. Z. N., Tsakok, T., Meynell, F., Coker, B., McAteer, H., Moorhead, L., Mackenzie, T., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.10.007 · Cited by 162
“0) Age (y), median (range) 48 (36-59) 49 (39-58) 50 (38-60) 46 (33-60) 0 Sex, no.”
Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer
Yan, J., Smyth, M. J., & Teng, M. W. L. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028530 · Cited by 149
“In mice and humans, a range of innate and adaptive immune cells have been shown to express IL-12 and IL-23 receptors constitutively as measured by qPCR, flow cytometry, or using an IL-23R GFP KI reporter mouse (Tables 3 and 4), although they appear to be expressed at varying levels, which can be further up-regulated f…”
BackgroundMethodNoviello, D., Mager, R., Roda, G., Borroni, R. G., Fiorino, G., & Vetrano, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.611256 · Cited by 161
IL-17A-mediated neutrophil recruitment limits expansion of segmented filamentous bacteria
Flannigan, K. L., Ngo, V. L., Geem, D., Harusato, A., Hirota, S. A., Parkos, C. A., Lukacs, N. W., Nusrat, A., Gaboriau‐Routhiau, V., Cerf–Bensussan, N., et al. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.80 · Cited by 159
IL-17 in the immunopathogenesis of spondyloarthritis
Taams, L. S., Steel, K. J. A., Srenathan, U., Burns, L. A., & Kirkham, B. W. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0044-2 · Cited by 158
T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer
Chang, S. H. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01146-9 · Cited by 158
Gut–Skin Axis: Unravelling the Connection between the Gut Microbiome and Psoriasis
Thye, A. Y.-K., Bah, Y.-R., Law, J. W.-F., Tan, L. T.-H., He, Y.-W., Wong, S.-H., Thurairajasingam, S., Chan, K.-G., Lee, L.-H., & Letchumanan, V. (2022) · Biomedicines · doi:10.3390/biomedicines10051037 · Cited by 156
The role of IL 23 in the treatment of psoriasis
Puig, L. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1292137 · Cited by 158
“Th17 cells can secrete several cytokines apart from IL-17, including TNF-α, IL-22, and IL-21 (which can act as an autocrine factor driving expansion of the Th17 lineage) [50].”
BackgroundThe Role of Th17 Response in COVID-19
Martonik, D., Parfieniuk‐Kowerda, A., Rogalska, M., & Flisiak, R. (2021) · Cells · doi:10.3390/cells10061550 · Cited by 156
“A wide array of cytokines, including IL-17A, IL-17F, IL-21, IL-22, granulocytemacrophage colony-stimulating factor (GM-CSF), IL-10 and IFN-γ are produced by the Th17 subset [30,32,33].”
BackgroundWang, M., Zhang, S., Zheng, G., Huang, J., Songyang, Z., Zhao, X., & Lin, X. (2018) · Immunity · doi:10.1016/j.immuni.2018.05.012 · Cited by 155
The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis
Paulissen, S. M. J., van Hamburg, J. P., Dankers, W., & Lubberts, E. (2015) · Cytokine · doi:10.1016/j.cyto.2015.02.002 · Cited by 158
Ritchlin, C. T., Kavanaugh, A., Merola, J. F., Schett, G. A., Scher, J. U., Warren, R. B., Gottlieb, A. B., Assudani, D., Bedford-Rice, K., Coarse, J., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33161-7 · Cited by 155
Innate Immune Response in Kidney Ischemia/Reperfusion Injury: Potential Target for Therapy
Kezić, A., Stajić, N., & Thaiss, F. (2017) · Journal of Immunology Research · doi:10.1155/2017/6305439 · Cited by 156
“The differentiation of Th17 cell is driven by NF-κB pathway activation through c-Rel induction of RAR-related orphan receptor gamma (RORγ1 and RORγ2) expression [95, 96].”
Mucocutaneous IL-17 immunity in mice and humans: host defense vs. excessive inflammation
Li, J., Casanova, J.-L., & Puel, A. (2018) · Mucosal Immunology · doi:10.1038/mi.2017.97 · Cited by 146
Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases
Abraham, C., Dulai, P. S., Vermeire, S., & Sandborn, W. J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.10.018 · Cited by 153
Wang, Z.-H., Gong, K., Liu, X., Zhang, Z., Sun, X., Wei, Z. Z., Yu, S. P., Manfredsson, F. P., Sandoval, I. M., Johnson, P. F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04120-z · Cited by 137
Targeting the interleukin-17 immune axis for cancer immunotherapy
Vitiello, G. A., & Miller, G. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190456 · Cited by 151
Phage-assisted continuous evolution of proteases with altered substrate specificity
Packer, M. S., Rees, H. A., & Liu, D. R. (2017) · Nature Communications · doi:10.1038/s41467-017-01055-9 · Cited by 131
The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
Tsukazaki, H., & Kaito, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176401 · Cited by 152
“Guselkumab Guselkumab targets the p19 subunit that is shared between IL‐23 and IL‐39 [103].”
BackgroundInfluentialBüettner, M., & Lochner, M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00342 · Cited by 149
T cells and autoimmune kidney disease
Suárez‐Fueyo, A., Bradley, S. J., Klatzmann, D., & Tsokos, G. C. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.34 · Cited by 148
GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage
Croxford, A. L., Spath, S., & Becher, B. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.08.004 · Cited by 146
Allergic airway inflammation: key players beyond the Th2 cell pathway
Hirose, K., Iwata, A., Tamachi, T., & Nakajima, H. (2017) · Immunological Reviews · doi:10.1111/imr.12540 · Cited by 146
Th17 and Cognitive Impairment: Possible Mechanisms of Action
Cipollini, V., Anrather, J., Orzi, F., & Iadecola, C. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00095 · Cited by 149
“Dysregulated IL-17 production and signaling have been involved in different autoimmune diseases (Gaffen et al., 2014), but the mechanisms are not yet fully understood.”
BackgroundGarg, A. V., Amatya, N., Chen, K., Cruz, J. A., Grover, P., Whibley, N., Conti, H. R., Hernandez Mir, G., Sirakova, T., Childs, E. C., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.021 · Cited by 145
“This concept is being exploited clinically with biologics targeting IL-17, the IL-17R, or Th17 cells (Gaffen et al., 2014).”
InfluentialSelf-citationPfaff, C. M., Marquardt, Y., Fietkau, K., Baron, J. M., & Lüscher, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-15892-7 · Cited by 144
Bloch, Y., Bouchareychas, L., Merceron, R., Składanowska, K., Van den Bossche, L., Detry, S., Govindarajan, S., Elewaut, D., Haerynck, F., Dullaers, M., et al. (2018) · Immunity · doi:10.1016/j.immuni.2017.12.008 · Cited by 134
“…( IL-12 , IL-23, IL-27, IL-35 IL-35) are predominantly produced by It is precisely the potency by which IL-23 can drive production of interleukin-17 (IL-17) by Th17 cells and IL-17-producing γδ T ( γδ T17) cells, that has propelled IL-23 to a major therapeutic target (Gaffen et al., 2014).”
BackgroundRole of Th17 and IL-17 Cytokines on Inflammatory and Auto-immune Diseases
Akhter, S., Tasnim, F. M., Islam, M. N., Rauf, A., Mitra, S., Emran, T. B., Alhumaydhi, F. A., Khalil, A. A., Aljohani, A. S. M., Abdulmonem, W. A., et al. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230904150808 · Cited by 144
T Helper Cell Subsets in Clinical Manifestations of Psoriasis
Diani, M., Altomare, G. F., & Reali, E. (2016) · Journal of Immunology Research · doi:10.1155/2016/7692024 · Cited by 138
“At the same time, genetic association studies together with human and mouse experimental data and the results of clinical trials have shifted the attention to IL-23/Th17 axis controlling mainly the proinflammatory loop in psoriatic plaques which involves keratinocytes, dendritic cells, and T cells [16, 17].”
Di, T., Ruan, Z.-T., Zhao, J., Wang, Y., Liu, X., Wang, Y., & Li, P. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2015.12.035 · Cited by 137
“Although Th1 T cells are the predominant cell type in psoriasis, Th17 cells are also implicated in the pathogenesis of plaque psoriasis [23].”
BackgroundThe roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity
Song, X., He, X., Li, X., & Qian, Y. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.105 · Cited by 137
The role of T cells in pemphigus vulgaris and bullous pemphigoid
Fang, H., Li, Q., & Wang, G. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102661 · Cited by 138
CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells
Kara, E. E., McKenzie, D. R., Bastow, C. R., Gregor, C. E., Fenix, K. A., Ogunniyi, A. D., Paton, J. C., Mack, M., Pombal, D. R., Seillet, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms9644 · Cited by 136
Safety of secukinumab in the treatment of psoriasis
Blauvelt, A. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1221923 · Cited by 135
“By binding to circulating and tissue IL-17A, secukinumab inhibits its interaction with the IL-17A receptor, thereby inhibiting downstream release of pro-inflammatory cytokines and chemokines that contribute to the development of psoriasis [16,17].”
BackgroundMolecular control of pathogenic Th17 cells in autoimmune diseases
Wu, B., & Wan, Y. Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106187 · Cited by 136
Haploinsufficiency of A20 causes autoinflammatory and autoimmune disorders
Kadowaki, T., Ohnishi, H., Kawamoto, N., Hori, T., Nishimura, K., Kobayashi, C., Shigemura, T., Ogata, S., Inoue, Y., Kawai, T., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.10.039 · Cited by 133
Navarro‐Compán, V., Puig, L., Vidal, S., Ramírez, J., Llamas‐Velasco, M., Fernández‐Carballido, C., Almodóvar, R., Pinto, J., Galíndez‐Aguirregoikoa, E., Zarco, P., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1191782 · Cited by 135
“This CBAD domain is part of a regulatory mechanism capable of coordinating the inhibition of IL-17s signaling through binding of TRAF3 to the ubiquitin-editing enzyme A20 (6).”
BackgroundInfluentialInnately versatile: γδ17 T cells in inflammatory and autoimmune diseases
Papotto, P. H., Reinhardt, A., Prinz, I., & Silva-Santos, B. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.11.006 · Cited by 119
Taylor, P. C., Choy, E., Baraliakos, X., Szekanecz, Z., Xavier, R. M., Isaacs, J. D., Strengholt, S., Parmentier, J. M., Lippe, R., & Tanaka, Y. (2023) · Rheumatology · doi:10.1093/rheumatology/kead448 · Cited by 132
“JAK2/ TYK2 heterodimers regulate the signalling of IL-12 and IL-23, key immunoregulatory cytokines implicated in CD4 þ Th1 and Th17 cell differentiation, respectively [7, 8].”
BackgroundMaekawa, T., Hosur, K., Abe, T., Kantarci, A., Ziogas, A., Wang, B., Van Dyke, T. E., Chavakis, T., & Hajishengallis, G. (2015) · Nature Communications · doi:10.1038/ncomms9272 · Cited by 119
“IL-17 signal transduction regulates a variety of proinflammatory and antimicrobial genes by activating NF-κ B and mitogen-activated protein kinase (MAPK) pathways as well as the CCAAT/enhancer-binding protein (C/EBP) family of transcription factors, such as C/EBP β and C/EBP δ 9 .”
Immune Interactions with Pathogenic and Commensal Fungi: A Two-Way Street
Underhill, D. M., & Pearlman, E. (2015) · Immunity · doi:10.1016/j.immuni.2015.10.023 · Cited by 130
“IL-17 receptor signaling involves recruitment of the Act1 adaptor molecule and activation of canonical NF-kB pathway leading to transcription of CXC chemokines, which are important for recruitment of neutrophils to sites of infection, and CCL20, which recruits CCR6-expressing Th17and IL-17-producing gd T cells (Gaffen…”
BackgroundInfluentialImmunity to Commensal Fungi: Detente and Disease
Wheeler, M. L., Limon, J. J., & Underhill, D. M. (2017) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100342 · Cited by 130
Wang, C., Zhang, C.-J., Martin, B. N., Bulek, K., Kang, Z., Zhao, J., Bian, G., Carman, J. A., Gao, J., Dongre, A., et al. (2017) · Nature Communications · doi:10.1038/ncomms15508 · Cited by 117
Paramsothy, S., Rosenstein, A. K., Mehandru, S., & Colombel, J. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0050-3 · Cited by 131
Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease
Eom, T., Kim, Y. S., Choi, C. H., Sadowsky, M. J., & Unno, T. (2018) · Journal of Microbiology · doi:10.1007/s12275-018-8049-8 · Cited by 117
Wang, H., Kjer-Nielsen, L., Shi, M., D’Souza, C., Pediongco, T. J., Cao, H., Kostenko, L., Lim, X. Y., Eckle, S. B. G., Meehan, B. S., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aaw0402 · Cited by 125
Singh, S., Kroe-Barrett, R. R., Canada, K. A., Zhu, X., Sepulveda, E., Wu, H., He, Y., Raymond, E. L., Ahlberg, J., Frego, L. E., et al. (2015) · mAbs · doi:10.1080/19420862.2015.1032491 · Cited by 122
“Antibodies that target IL17A, IL17RA, and IL17A/IL17F (a shared motif) are now in clinical trials for a variety of autoimmune diseases, including psoriasis, rheumatoid arthritis, Crohn’s disease, ankylosing spondylitis, and psoriatic arthritis.(2) We focused on generation of a selective and potent antibody directed to…”
BackgroundInfluentialInterleukin‐23 pathway at the enthesis: The emerging story of enthesitis in spondyloarthropathy
Bridgewood, C., Sharif, Κ., Sherlock, J. P., Watad, ., & McGonagle, D. (2020) · Immunological Reviews · doi:10.1111/imr.12840 · Cited by 128
Immunology of the ageing kidney
Sato, Y., & Yanagita, M. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0185-9 · Cited by 126
Treatment of psoriasis with NFKBIZ siRNA using topical ionic liquid formulations
Mandal, A., Kumbhojkar, N., Reilly, C. B., Dharamdasani, V., Ukidve, A., Ingber, D. E., & Mitragotri, S. (2020) · Science Advances · doi:10.1126/sciadv.abb6049 · Cited by 126
Plasticity in Pro- and Anti-tumor Activity of Neutrophils: Shifting the Balance
Furumaya, C., Martínez-Sanz, P., Bouti, P., Kuijpers, T. W., & Matlung, H. L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02100 · Cited by 126
Insights into IL-23 biology: From structure to function
Floss, D. M., Schröder, J., Franke, M., & Scheller, J. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.005 · Cited by 126
“of IL-23R is restricted to specific T cell subsets [8], a small number of B cells and innate lymphoid cells [56].”
BackgroundInfluentialIκBζ is a key driver in the development of psoriasis
Johansen, C., Mose, M., Ommen, P., Bertelsen, T., Vinter, H., Hailfinger, S., Lorscheid, S., Schulze-Osthoff, K., & Iversen, L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509971112 · Cited by 125
“The adaptor protein Act1 is one of the key components in the IL-17 signaling pathway (44), and recently Act1-mediated signaling was demonstrated to play an essential role in imiquimodinduced psoriasis-like skin inflammation (45).”
BackgroundBlauvelt, A., Gooderham, M., Iversen, L., Ball, S. G., Zhang, L., Agada, N. O., & Reich, K. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.06.153 · Cited by 125
Wang, L., Aschenbrenner, D., Zeng, Z., Cao, X., Mayr, D., Mehta, M., Capitani, M., Warner, N. E., Pan, J., Wang, L., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00803-4 · Cited by 125
Mesenchymal stem cells and adaptive immune responses
Cao, W., Cao, K., Cao, J., Wang, Y., & Shi, Y. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.06.003 · Cited by 125
Aschenbrenner, D., Quaranta, M., Banerjee, S., Ilott, N., Jansen, J., Steere, B., Chen, Y.-H., Ho, S., Cox, K., Arancibia-Cárcamo, C. V., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321731 · Cited by 123
Lee, J., Aoki, T., Thumkeo, D., Siriwach, R., Yao, C., & Narumiya, S. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.05.036 · Cited by 123
“Although it was shown that IL-23 signaling induces expression of TH17 pathogenic signature genes through activation of STAT3,(31,32) transcription factors other than STAT3 are also implicated for induction of pathogenic TH17 cells because IL-6, which activates STAT3 similarly to IL-23, cannot induce IL-23R gene expres…”
BackgroundPericolini, E., Gabrielli, E., Amacker, M., Kasper, L., Roselletti, E., Luciano, E., Sabbatini, S., Kaeser, M., Moser, C., Hube, B., et al. (2015) · mBio · doi:10.1128/mbio.00724-15 · Cited by 109
“Nonetheless, contrasting data have been reported on this topic (23, 40, 41).”
BackgroundMuch More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer
Brevi, A., Cogrossi, L. L., Grazia, G., Masciovecchio, D., Impellizzieri, D., Lacanfora, L., Grioni, M., & Bellone, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.565470 · Cited by 121
The immunomodulatory oligodendrocyte
Zeis, T., Enz, L., & Schaeren-Wiemers, N. (2016) · Brain Research · doi:10.1016/j.brainres.2015.09.021 · Cited by 120
Tissue-infiltrating neutrophils represent the main source of IL-23 in the colon of patients with IBD
Kvedaraite, E., Lourda, M., Ideström, M., Chen, P., Olsson‐Åkefeldt, S., Forkel, M., Gavhed, D., Lindforss, U., Mjösberg, J., Henter, J., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-309014 · Cited by 120
Humanized mouse models of immunological diseases and precision medicine
Shultz, L. D., Keck, J., Burzenski, L., Jangalwe, S., Vaidya, S., Greiner, D. L., & Brehm, M. A. (2019) · Mammalian Genome · doi:10.1007/s00335-019-09796-2 · Cited by 109
Metadata
- Authors
- Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Cua, Daniel J.
- Venue
- Nature reviews. Immunology
- Published
- 2014-08-22
- Volume
- 14
- Issue
- 9
- Pages
- 585-600
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC4281037
- OpenAlex
- W2064645845
- Cited by
- 1,585
- References
- 187
- Citations by year
- 2026: 119 · 2025: 104 · 2024: 111 · 2023: 126 · 2022: 118 · 2021: 159 · 2020: 162 · 2019: 131 · 2018: 153 · 2017: 155 · 2016: 129 · 2015: 111 · 2014: 6
- FWCI
- 13.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI107825, AI107825)
- National Institute of Dental and Craniofacial Research (R01DE022550, R01DE023815, DE022550)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- IL-23, IL-17, Th17 cells, T cell lineage commitment, transcriptional regulation, IL-17 signaling, mesenchyme, immune-mediated inflammatory diseases, therapeutic antibodies
- MeSH terms
- Antibodies, Autoimmune Diseases, Epithelial Cells, Humans, Transcription, Genetic, Signal Transduction, Cytokines, Tight Junctions, Interleukin-17, Receptors, Interleukin-17, Interleukin-23, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.